FOS and diabetic kidney disease: Building upon previous findings, the therapeutic effect of AS on DKD is likely associated with the attenuation of podocyte apoptosis and the regulation of ECM homeostasis, potentially through the inhibition of the MAPK/FOS signaling pathway.